Announcements Trials
Browse Landscape

Status

Withdrawn 1

Sponsor Class

NIH 1

Study Type

Observational 1

Sponsor

Conditions

Recurrence 1Neoplasms 1Death 1

Interventions

Specimen Handling 12Magnetic Resonance Spectroscopy 11Cyclophosphamide 10Biological Therapy 9Drug Therapy 8Dexamethasone 7Biopsy 7antineoplaston A10 6Nivolumab 6Complementary Therapies 6fludarabine 5antineoplaston AS 2-1 5aldesleukin 5Ipilimumab 5Etoposide 5Doxorubicin 5Cisplatin 5atezolizumab 4Vincristine 4Surgical Procedures, Operative 4Rituximab 4Paclitaxel 4Chemotherapy, Adjuvant 42,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 4venetoclax 3olaparib 3dexamethasone acetate 3dexamethasone 21-phosphate 3copanlisib 3auricularum 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × NIH × Quality Assurance, Health Care × Clear all
NCT07484282 2026-04-03

Quality of Care for Adolescent and Young Adult (AYA) Patients Living With Serious or Advanced Cancer

National Institutes of Health Clinical Center (CC)

Withdrawn

Death, Neoplasms, Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon âš¡